Loading organizations...

§ Private Profile · Dallas, TX, USA
Recuro Health is a technology company.
Recuro Health delivers an integrated digital platform for virtual care, including primary, behavioral, and urgent services. The company emphasizes comprehensive patient monitoring and a proactive digital medical home, shifting healthcare from reactive treatment to continuous, preventative engagement. This approach forms a complete continuum of virtual care for its users.
Michael Gorton founded Recuro Health in 2021, leveraging his background as Teladoc's founding CEO. Gorton's insight was the need for a more holistic, integrated virtual care model to advance healthcare accessibility and outcomes. He aimed to build a comprehensive digital platform extending beyond traditional episodic virtual visits.
Recuro Health's digital solutions serve individual members, employers, and health plans. Its mission is making advanced healthcare broadly accessible. The company envisions individuals receiving comprehensive, proactive care directly at home, fundamentally redefining traditional healthcare delivery through continuous health engagement.
Recuro Health has raised $62.0M across 2 funding rounds.
Recuro Health has raised $62.0M in total across 2 funding rounds.
Recuro Health has raised $62.0M across 2 funding rounds. Most recently, it raised $47.0M Series B in April 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2023 | $47M Series B | Robert Nelsen | ARCH Venture Partners, F Prime Capital, FTX Ventures, General Catalyst, LUX Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan Mccabe, Karim Atiyeh, Scott Belsky, 4D Capital, Flippen Group, Green Park & Golf Ventures | Announced |
| Aug 1, 2021 | $15M Series A | ARCH Venture Partners | F Prime Capital, FTX Ventures, General Catalyst, LUX Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan Mccabe, Karim Atiyeh, Scott Belsky, 1843 Capital, Cortado Ventures, William Paiva, Sage Venture Partners | Announced |
Recuro Health is a technology company founded in 2021 that builds a virtual-first care delivery platform offering personalized, proactive virtual health services.[2][1][3] It serves employers, providers, and managed care organizations by solving access barriers in healthcare through integrated primary care, behavioral health, urgent care, supplemental benefits like pharmacy and care management, at-home lab testing, and genomics—all on a single, customizable, HITRUST-certified SaaS platform.[1][2][3][5] The platform shifts from reactive "sick care" to preventative care via health risk assessments, no utilization caps, multilingual support (over 100 languages), and potential savings of 25-30% on lost productivity, earning awards like Newsweek's World's Best Digital Health Companies and TIME's Top HealthTech.[1][3][4][7]
Recuro Health was founded in 2021 and is headquartered in Coppell, Texas.[2] While specific founders are not detailed in available sources, the company emerged amid the COVID-19 pandemic's surge in virtual care adoption, transforming marginal digital health use into widespread utilization.[3] Early traction came from developing a "Digital Medical Home" platform that integrates virtual services with proactive tools like genomic testing and health risk assessments, prioritizing prevention over reaction.[1][3][5] Pivotal moments include recognitions such as Newsweek's World's Best Digital Health Companies, TOP 10 in telehealth by Becker’s Hospital Review, and TIME's Top 25 HealthTech, solidifying its market position.[4][7]
Recuro rides the post-COVID telehealth boom, accelerating the shift to virtual-first, preventative care amid rising chronic diseases and demand for accessible, data-driven health solutions.[1][3][5] Timing aligns with AI advancements in clinical decision-making, RPM wearables, and genomic testing, enabling scalable platforms that integrate fragmented services for payers and employers.[5][6] Market forces like value-based care, cybersecurity needs, and hybrid virtual/brick-and-mortar models favor Recuro's holistic approach, influencing the ecosystem by promoting interoperable "Digital Medical Homes" that lower costs, boost engagement, and reduce readmissions.[1][3][5]
Recuro is poised to expand its AI-leveraged tools (e.g., personalized marketing and clinical predictions) and virtual offerings amid 2025's digital health focus on infrastructure, RPM, and genomics.[1][5][6] Trends like AI-driven outcomes, multilingual scalability, and employer-sponsored benefits will shape growth, potentially amplifying influence through partnerships and white-label expansions. As a leader in proactive telehealth, Recuro will likely deepen its role in making advanced care ubiquitous, building on its accessible platform to drive sustained health improvements and savings.
Recuro Health has raised $62.0M in total across 2 funding rounds.
Recuro Health's investors include Robert Nelsen, ARCH Venture Partners, F-Prime Capital Partners, FTX Ventures, General Catalyst, Lux Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh.